ResearcherKindai UniversityActive in the last 2 years
Teruaki Takasaki
Matched on ORCID iD 0000-0002-7670-1896; OpenAlex author ID A5089375210. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2022: 1 paper · 2023: 1 paper · 2024: 1 paper
Papers 3
- ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Cancer Cells. Co-author DOI 10.1155/2024/7683793↗
- ACAGT-007a, an anti-cancer compound that modulates ERK MAPK signaling, induces nuclear enrichment of phosphorylated ERK in T3M4 pancreatic cancer cells. Co-author DOI 10.1111/gtc.13026↗
- ACAGT-007a, an ERK MAPK Signaling Modulator, in Combination with AKT Signaling Inhibition Induces Apoptosis in KRAS Mutant Pancreatic Cancer T3M4 and MIA-Pa-Ca… Co-author DOI 10.3390/cells11040702↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Golam Iftakhar Khandakar · 3 shared papers, 2022–2024 · strength 0.55
- Paper ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Ca… DOI 10.1155/2024/7683793↗
- Paper ACAGT-007a, an anti-cancer compound that modulates ERK MAPK signaling, induces nuclear enrichment of phosphorylated ERK… DOI 10.1111/gtc.13026↗
- Paper ACAGT-007a, an ERK MAPK Signaling Modulator, in Combination with AKT Signaling Inhibition Induces Apoptosis in KRAS Mut… DOI 10.3390/cells11040702↗
- Reiko Sugiura · 3 shared papers, 2022–2024 · strength 0.55
- Paper ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Ca… DOI 10.1155/2024/7683793↗
- Paper ACAGT-007a, an anti-cancer compound that modulates ERK MAPK signaling, induces nuclear enrichment of phosphorylated ERK… DOI 10.1111/gtc.13026↗
- Paper ACAGT-007a, an ERK MAPK Signaling Modulator, in Combination with AKT Signaling Inhibition Induces Apoptosis in KRAS Mut… DOI 10.3390/cells11040702↗
- Kazuto Nishio · 2 shared papers, 2022–2024 · strength 0.37
- Paper ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Ca… DOI 10.1155/2024/7683793↗
- Paper ACAGT-007a, an ERK MAPK Signaling Modulator, in Combination with AKT Signaling Inhibition Induces Apoptosis in KRAS Mut… DOI 10.3390/cells11040702↗
- Hitoshi Okada · 1 shared paper, 2024 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.